Pancreatic cancer drug is fast-tracked

The US Food and Drugs Administration has given priority approval to new treatment BC819 from Israel’s Biocancell Therapeutics.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000687932&fid=1725

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.